R / 001

Technical claims should survive hostile reading.

Deep investigations of AI and quantum systems from explicitly disclosed libertarian, anarcho-capitalist, and accelerationist priors. Evidence does not inherit the politics.

The publication contract

01

Claims have coordinates

Observations, estimates, inferences, reports, and priors are labeled and tied to sources.

02

Counterevidence changes the paper

The strongest objections appear inside the argument with their disposition and resulting revision.

03

Uncertainty remains visible

Unknown is not zero. Public corrections are permanent, dated, and linked to affected claims.

Published analyses

  1. When Inference Compute Helps: Search, Verification, and the Cost of Better AnswersAugust 10, 2026 · medium confidence
  2. Post-Training Gains Still Depend on the Base ModelAugust 10, 2026 · medium confidence

QUEUE / 16

Commissioned investigations

Publication is sequential. A commission goes live only after source control, adversarial review, and release checks pass.

AI models

  1. Post-Training Gains Still Depend on the Base Modelpublished
  2. When Inference Compute Helps: Search, Verification, and the Cost of Better Answerspublished
  3. The Benchmark Is the Product Demo: How Frontier-Model Evals Misleadforthcoming
  4. The Inference Price War: When Intelligence Becomes a Commodityforthcoming
  5. Open Weights: Competitive Infrastructure or an Irreversible Subsidy to Misuse?forthcoming
  6. Autonomous Agents: Reliability Is the Constraint, Not Intelligenceforthcoming

AI hardware

  1. The AI Factory Is an Electricity-and-Network Businessforthcoming
  2. The Hidden AI Chokepoint: Memory, Packaging, and Interconnectforthcoming
  3. AI Export Controls: Security Margin or Cartel Shield?forthcoming
  4. CHIPS Act Scorecard: Dollars, Wafers, Delays, and Deadweightforthcoming

Everything else AI

  1. Robots, Wages, and the Missing Productivity Denominatorforthcoming
  2. Nuclear for Compute: Is Licensing the Bottleneck or the Excuse?forthcoming
  3. One-Patient Medicines and the Regulatory Economics of AI-Assisted Genome Editingforthcoming
  4. AI Drug Discovery: Count Validated Molecules, Not Partnershipsforthcoming

Quantum

  1. Quantum Utility Before Quantum Advantageforthcoming
  2. A Quantum Benchmark That Cannot Hide Behind Qubit Countforthcoming

Topics

Model systems, compute infrastructure, deployed AI, and quantum computing. Topic archives become available with the first published analysis in each section.